Vascutek
Terumo Aortic is a global medical device company dedicated to developing innovative solutions that improve outcomes for patients with aortic and peripheral vascular disease. They focus on creating effective management options for aortic disease, including thoracic, abdominal, and peripheral aneurysms, dissections, and occlusions. Their mission is to contribute to society through healthcare by providing comprehensive aortic solutions and partnering with the clinical community to develop innovative treatments.
Industries
Nr. of Employees
large (251-1000)
Vascutek
Vascutek Ltd, Newmains Avenue, Inchinnan, Renfrewshire, PA4 9RR, United Kingdom
Patents
Products
Abdominal endovascular stent-graft system
Trimodular abdominal endograft platform designed for endovascular aneurysm repair with modular limb adjustability, dual proximal fixation and configurable fenestration/fit options.
Thoracic branched endograft systems
Custom and off-the-shelf branched thoracic endograft platforms for aortic arch pathologies incorporating branch tunnels, branch limb designs and lock-stent options to manage supra-aortic vessels.
Hybrid surgical graft (surgical graft with integrated stent)
Hybrid frozen-elephant-trunk style grafts combining textile surgical grafts with an integrated self-expanding stent component to support combined open and endovascular repairs.
Low-profile aortic balloon and expansion devices
Low-profile intravascular balloon devices offering controlled inflation across a range of diameters to assist aortic expansion during endovascular procedures.
Abdominal endovascular stent-graft system
Trimodular abdominal endograft platform designed for endovascular aneurysm repair with modular limb adjustability, dual proximal fixation and configurable fenestration/fit options.
Thoracic branched endograft systems
Custom and off-the-shelf branched thoracic endograft platforms for aortic arch pathologies incorporating branch tunnels, branch limb designs and lock-stent options to manage supra-aortic vessels.
Hybrid surgical graft (surgical graft with integrated stent)
Hybrid frozen-elephant-trunk style grafts combining textile surgical grafts with an integrated self-expanding stent component to support combined open and endovascular repairs.
Low-profile aortic balloon and expansion devices
Low-profile intravascular balloon devices offering controlled inflation across a range of diameters to assist aortic expansion during endovascular procedures.
Services
Design and manufacture of custom-made endovascular and hybrid grafts per written prescription, including feature customization (fenestrations, scallops, branches), verification by clinical planners and device engineers, and delivery logistics.
Planning and execution support for prospective multi-center studies, post-approval studies and long-term registries to capture device performance and safety data.
Electronic delivery of instructions for use, indications, contraindications, and warnings via an online eIFU portal.
Design and manufacture of custom-made endovascular and hybrid grafts per written prescription, including feature customization (fenestrations, scallops, branches), verification by clinical planners and device engineers, and delivery logistics.
Planning and execution support for prospective multi-center studies, post-approval studies and long-term registries to capture device performance and safety data.
Electronic delivery of instructions for use, indications, contraindications, and warnings via an online eIFU portal.
Expertise Areas
- Aortic and peripheral vascular device development
- Endovascular delivery system engineering
- Custom medical device design and manufacturing
- Graft textile and implant materials (polyester, ePTFE)
Key Technologies
- Nitinol self-expanding stents
- Woven and knitted polyester grafts
- Expanded PTFE (ePTFE) grafts
- Fenestrated and branched endograft architecture
News & Updates
Awarded on 30 May 2025, recognizing excellence in aortic medical devices.
Received on 20 May 2024, acknowledging innovation in healthcare solutions.
A post-approval study for the Thoraflex Hybrid device, a significant milestone in aortic arch treatment.
Awarded for excellence in healthcare innovation and contribution to society.
Awarded on 30 May 2025, recognizing excellence in aortic medical devices.
Received on 20 May 2024, acknowledging innovation in healthcare solutions.
A post-approval study for the Thoraflex Hybrid device, a significant milestone in aortic arch treatment.
Awarded for excellence in healthcare innovation and contribution to society.